Novo Nordisk shares fall after heart medicine trial results
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…
Novo Nordisk looks to block Eli Lilly weight-loss drug ads
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters Novo Nordisk said on…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
39 Sweeteners Put to the Test Produced Surprising Gut Changes
Cambridge scientists found that many widely used sweeteners can directly change how gut bacteria grow, especially when mixed…
Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat pet
A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
Popular diabetes drugs do not alter the risk of developing a blinding eye condition
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
Natasha never expected to become addicted to prescribed opioids while battling endometriosis
Natasha Trajkovski was 21 when she was first prescribed opioids. After having a C-section, she was diagnosed with…
UnitedHealth Group (UNH) earnings Q2 2026
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
Newly Identified Inhibitors May Boost Chemotherapy Drug’s Ability to Fight Treatment-Resistant Cancers
Newswise — In a new report of research, scientists at Johns Hopkins University School of Medicine and Johns…
Johnson & Johnson has a chance to show it’s more than just a rotation winner
Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…